EXAGEN INC. (XGN)

EXAGEN INC. (XGN) scores 40 out of 100 on boothcheck's 11-model valuation framework. Verdict: Bad The estimated fair value is 2.62, representing a 15% premium to fair value. Quantitative score: 33/100. Qualitative score: 90/100.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full XGN analysis on boothcheck